MPH Health Care Forecast | Price, Price Target & Analyst Assessment

MPH Health Care

DB:93M1

€ 18,65

€0,00 (0,00%)

18,65 €

€0,00 (0,00%)

End-of-day quote: 04/08/2026

MPH Health Care Stock Value

The current analyst recommendation for DB:93M1 is: Outperform.

Outperform

MPH Health Care Company Info

EPS Growth 5Y

-22,01%

Market Cap

€0,08 B

Long-Term Debt

€0,01 B

Quarterly earnings

04/17/2026

Dividend

€0,00

Dividend Yield

0,00%

Founded

2008

Industry

Health Care

Country

Germany

Website

MPH Health Care

ISIN Number

DE000A289V03

Website

http://www.mph-ag.de

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

€37,00

98.39%

Last Update: 04/09/2026

Analysts: 1

Highest Price Target €37,00

Average Price Target €37,00

Lowest Price Target €37,00

In the last five quarters, MPH Health Care’s Price Target has fallen from €200,98 to €65,80 - a -67,26% decrease. One analysts predict that MPH Health Care’s share price will increase in the coming year, reaching €37,00. This would represent an increase of 98,39%.

Top growth stocks in the health care sector (5Y.)

What does MPH Health Care do?

MPH Health Care AG is an investment entity that focuses primarily on the health care and pharmaceutical sectors. This company operates within the dynamic investment landscape, where it actively engages in financial investments predominantly concentrated in the realm of health care, specifically in Germany. The investments are varied, with a strong emphasis on companies specializing in plastic surgery, aesthetic medical beauty treatments, pharmaceutical trading particularly in oncology, and oth...

The investments are varied, with a strong emphasis on companies specializing in plastic surgery, aesthetic medical beauty treatments, pharmaceutical trading particularly in oncology, and other chronic disease treatments. The organization capitalizes on the opportunities presented within this growing market, synergizing its investment strategies with emerging trends in health care.

Business Segments

The company operates through health care and pharmaceuticals segments.

The core focus is on the health care market, specifically areas related to aesthetic medicine, pharmaceutical distribution for conditions such as oncology, and the provision of medical treatments that enhance lifestyle options. This singular focus allows the organization to maximize efficiency and resource allocation towards its investments, optimizing returns.

Within the pharmaceutical segment, the company's involvement encompasses the distribution of medications vital for managing chronic diseases and therapeutic areas, notably oncology and HIV. This segment is spearheaded by HAEMATO AG, a vital player within the portfolio that focuses on pharmaceutical trading while coping with various market pressures, including constant regulatory measures and competitive dynamics.

Business Strategy

The business strategy of the company revolves around leveraging growth opportunities in the health care sector through concentrated investments in high-potential firms. The company emphasizes a focused approach wherein investments are made in sectors that are not only growing but also aligned with emerging consumer and health trends. The strategy is entrenched in a thorough analysis of market trends and an acute awareness of regulatory environments that govern the health care landscape.

Products and Services

The company's portfolio is diverse, encompassing a wide range of products and services primarily related to health care. The core of its offerings is based on investments in companies that operate within the health care and pharmaceutical sectors, specifically targeting innovative medical treatments and pharmaceuticals for chronic illnesses.

A critical component of its offering includes partnerships with aesthetic medicine providers such as M1 Kliniken AG. These establishments deliver an array of beauty treatments, focusing on enhancing customer satisfaction through advanced techniques and personalized care. By tapping into the growing societal focus on aesthetics, these clinics serve a dual role of meeting customer demand while driving significant returns for the company.

Additionally, the company is engaged in pharmaceutical trading through HAEMATO AG, which specializes in distributing essential medications, particularly in oncology and HIV. This not only addresses critical health needs but also positions the company strategically within the pharmaceutical distribution network, capitalizing on both demand and innovative products coming to market.

Geographical Markets Served

The company predominantly operates within the German market, leveraging the localized nature of its investments. The concentrated focus on Germany allows the company to capitalize on specific market trends and regulatory environments unique to this region. The strategy is crafted to optimize investment returns by aligning closely with the national health care priorities and consumer behavior pertaining to medical treatments.

Seasonality

The business activities of the company are generally not characterized by significant seasonality. However, demand for aesthetic medical treatments can exhibit seasonal trends influenced by factors such as fashion cycles, consumer spending behaviors, and economic conditions. Nonetheless, the company's diversified investment portfolio mitigates the impacts of any seasonal fluctuations, ensuring stable revenue streams throughout the year.

Customers

The company does not directly serve customers in the traditional sense since it functions predominantly as an investment entity. However, its portfolio companies, such as M1 Kliniken AG and HAEMATO AG, serve a diverse range of clients including individual consumers seeking aesthetic treatments and healthcare providers in need of essential pharmaceuticals. The organization's customer base ultimately spans various segments that benefit from innovative health care solutions and enhancements.

Sales and Marketing

The company employs various sales and marketing strategies through its subsidiaries. The marketing approaches include direct-to-consumer advertising for aesthetic services, targeted campaigns in health-related publications, and participation in industry events to build brand visibility. The company also capitalizes on digital marketing platforms to reach wider audiences, aligning with evolving consumer engagement trends.

History

The company was founded in 2008. The company was formerly known as MPH Mittelständische Pharma Holding AG and changed its name to MPH Health Care AG in 2017.

New support ticket

Explore

MPH Health Care Stock Value

MPH Health Care Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does MPH Health Care do?

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

MPH Health Care Stock Value

MPH Health Care Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does MPH Health Care do?

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.